Public signalCompany raiseAuto-indexed · Unverified
Pheast Therapeutics, Inc. raised $75.3M
Pheast Therapeutics, Inc.· REDWOOD CITY, US· Other Technology· Filed Apr 10, 2025
Pheast Therapeutics, Inc. reported raising capital. Based in REDWOOD CITY, CALIFORNIA, US. First sale reported 2022-01-31. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$75.3M
Confidence90%
Raised
$75.3M
Investors
7
Incorporated
2020
Jurisdiction
DELAWARE
On the record
- Location
- REDWOOD CITY, US
- Sector
- Other Technology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $75.3M
- Target amount
- $75.3M
- Filing date
- Apr 10, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2020
- Industry group
- Other Technology
- Number of investors
- 7
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $75.3M
- Amendment
- Yes
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 75,250,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Apr 10, 2025. Details beyond the filing have not been verified.
Tags
AmendmentUSCompanyOther Technology$10M – $100MCompany Raise
Are you associated with Pheast Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record